Inflammatory Bowel Disease (IBD) Treatment Market Drivers, Segments, and Future Trends (2024-2032)

The Inflammatory Bowel Disease (IBD) treatment market, which includes therapies for both Crohn’s disease and ulcerative colitis, is rapidly growing in response to increasing incidence rates and advancements in medical research. The market was valued at USD 19.6 billion in 2023 and is projected to grow at a CAGR of 5.71%, reaching USD 32.3 billion […]